Phastar is a leading, award-winning, specialist Biometrics CRO that provides statistical consulting, analysis, reporting, data management and data science services to small and large biotechnology, pharmaceutical and medical device companies across the world. We leverage collaboration, technology, clinical data, and our worldwide presence to optimize decision-making for safety, quality, and efficiency. With 15 offices worldwide, our number one priority is ensuring on-time, quality work and assisting our customers in optimizing their clinical research. For more information, please visit https://phastar.com/

CellGenix and Albumedix, now part of Sartorius -- a trusted partner of the life science and biopharmaceutical industry -- offer developers high-quality, consistent, and dependable raw materials. Join us and discover more about our cytokine, media, and recombinant albumin solutions, and how they can drive your project forward.

As a CLIA/CAP accredited laboratory, we support translational research and clinical trials. We leverage advanced laboratory technologies to provide diagnostic and discovery modules including histology, spatial biology, digital pathology, image analysis, pathology central review, liquid biopsy, proteomics, genomics, and biomarker discovery and validation.

BioLineRx Ltd. (NASDAQ/TASE: BLRX) is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. The company’s first approved product is APHEXDA® (motixafortide) with an indication in the U.S. for stem cell mobilization for autologous transplantation in multiple myeloma. BioLineRx is advancing a pipeline of investigational medicines for patients with sickle cell disease, pancreatic cancer, and other solid tumors. Headquartered in Israel, and with operations in the U.S., the company is driving innovative therapeutics with end-to-end expertise in development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.

Learn more about who we are, what we do, and how we do it at www.biolinerx.com, or on Twitter and LinkedIn.  

Invus is a global equity investment firm with an evergreen capital structure, operating out of offices in the U.S., Europe and Asia. Since its founding in 1985, Invus has focused on empowering entrepreneurs and entrepreneurial teams to transform their industries across both public and private equity investments.

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. For more information, visit https://guardanthealth.com/

Leading scientists and researchers turn to Flywheel to accelerate their work and collaborate with ease. Our medical imaging AI platform streamlines the massive tasks of data discovery, aggregation, and curation; automates research workflows; and scales on demand. For more information, visit https://flywheel.io/.

As a global company WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through our unique business models, our integrated, end-to-end services help customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. For more information visit www.advancedtherapies.com.

Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development. With deep therapeutic and regulatory expertise and an expansive global footprint across the Asia-Pacific region, North America, and Europe, Novotech offers clients an accelerated path to bring life-changing therapies to market. For more information, please visit https://novotech-cro.com/ 

Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.

Grand River Aseptic Manufacturing, Inc. (“GRAM”) is a leading contract development and manufacturing organization with advanced equipment and innovative technology that delivers customized solutions to meet clients’ fill and finish needs for liquid vials, lyophilized vials, syringes, and cartridges. With biologic, small molecule, and vaccine capabilities, Grand River Aseptic Manufacturing supports pharmaceutical development, cGMP manufacturing, analytical testing, and regulatory filing. To learn more, please visit https://www.grandriverasepticmfg.com/

PredxBio is a TechBio company, headquartered in Pittsburgh, harnessing the power of spatial biology to unravel the hidden circuitries of the tumor microenvironment and getting to the “Why?” of cancer. Demonstrating a clear impact today, we have established an impressive accuracy in predicting patient responses to immunotherapy across the most critical cancers. Our ground-breaking platform aims to transform cancer care with next generation spatial analytics and explainable AI, thereby accelerating advancements in drug development and clinical trials. PredxBio opens a new era with far-reaching implications for biomarker discovery and clinical research with promising results in understanding disease progression and response to therapy. For more information please reach us at info@predxbio.com